The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease (Q49087290)

18 February 2018

title

The role of interleukin-6 in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease (English)

1 reference

18 February 2018

chronic obstructive pulmonary disease

main subject

1 reference

1 reference

1 reference

18 February 2018

Ken R Bracke

1 reference

18 February 2018

Tania Maes

1 reference

18 February 2018

author name string

Charles Pilette

1 reference

18 February 2018

Guy F Joos

1 reference

18 February 2018

Guy G Brusselle

1 reference

18 February 2018

publication date

1 October 2010

1 reference

18 February 2018

Experimental Lung Research

published in

1 reference

18 February 2018

volume

1 reference

18 February 2018

issue

1 reference

18 February 2018

page(s)

469-483

1 reference

18 February 2018

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

cites work

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Interleukin 6: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Interleukin-6 in aging and chronic disease: a magnificent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Interleukin-6 and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Directing transition from innate to acquired immunity: defining a role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Time course of cigarette smoke-induced pulmonary inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

The weight of leptin in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

CCR7 modulates pulmonary and lymph node inflammatory responses in cigarette smoke-exposed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

B1 B cell numbers and antibodies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Systemic effects in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Defective inflammatory response in interleukin 6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Extrapulmonary Manifestations of Chronic Obstructive Pulmonary Disease in a Mouse Model of Chronic Cigarette Smoke Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Reduced exercise endurance in interleukin-6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Emerging pharmacotherapies for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

Systemic Effects of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01902141003739723

10.3109/01902141003739723

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018